We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
AUM
$686M
AUM Growth
+$55.2M
Cap. Flow
+$15.1M
Cap. Flow %
2.21%
Top 10 Hldgs %
56.62%
Holding
1,072
New
55
Increased
132
Reduced
291
Closed
261

Sector Composition

Rank Sector Weight
1 Healthcare 20.53%
2 Financials 6.47%
3 Technology 5.45%
4 Consumer Discretionary 3.18%
5 Energy 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAN
601
DELISTED
The Aaron's Company Inc
AAN
$6.75K ﹤0.01%
699
WPM icon
602
Wheaton Precious Metals
WPM
$70.9B
$6.74K ﹤0.01%
140
DNA icon
603
Ginkgo Bioworks
DNA
$487M
$6.65K ﹤0.01%
125
PLUG icon
604
Plug Power
PLUG
$3.03B
$6.6K ﹤0.01%
563
+76
+16% +$1.09K
RIVN icon
605
Rivian
RIVN
$23.6B
$6.58K ﹤0.01%
425
+68
+19% +$1.15K
TTEC icon
606
TTEC Holdings
TTEC
$68M
$6.4K ﹤0.01%
172
ENTG icon
607
Entegris
ENTG
$21.8B
$6.4K ﹤0.01%
78
-49
-39% -$3.97K
ZBRA icon
608
Zebra Technologies
ZBRA
$17B
$6.36K ﹤0.01%
20
-3
-13% -$906
RPRX icon
609
Royalty Pharma
RPRX
$27.5B
$6.34K ﹤0.01%
176
DFTX
610
Definium Therapeutics
DFTX
$5.88B
$6.34K ﹤0.01%
1,999
VRSK icon
611
Verisk Analytics
VRSK
$24.5B
$6.14K ﹤0.01%
32
+3
+10% +$543
PEN icon
612
Penumbra
PEN
$12.7B
$6.13K ﹤0.01%
22
XBI icon
613
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$6.1K ﹤0.01%
80
LCID icon
614
Lucid Motors
LCID
$1.95B
$6.03K ﹤0.01%
75
+2
+3% +$178
PENN icon
615
PENN Entertainment
PENN
$2.39B
$5.93K ﹤0.01%
200
ETB
616
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$459M
$5.87K ﹤0.01%
450
OKTA icon
617
Okta
OKTA
$23.4B
$5.78K ﹤0.01%
67
-23
-26% -$1.75K
IQV icon
618
IQVIA
IQV
$43B
$5.77K ﹤0.01%
29
-23
-44% -$4.92K
PTCT icon
619
PTC Therapeutics
PTCT
$6.07B
$5.76K ﹤0.01%
119
REGN icon
620
Regeneron Pharmaceuticals
REGN
$83.9B
$5.75K ﹤0.01%
7
-6
-46% -$4.53K
GLW icon
621
Corning
GLW
$132B
$5.58K ﹤0.01%
158
XPEV icon
622
XPeng
XPEV
$11.2B
$5.55K ﹤0.01%
500
XRAY icon
623
Dentsply Sirona
XRAY
$2.18B
$5.5K ﹤0.01%
140
-54
-28% -$1.98K
ME
624
DELISTED
23andMe Holding Co
ME
$5.48K ﹤0.01%
120
EEMV icon
625
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.63B
$5.46K ﹤0.01%
100

Similar funds

Crewe Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Crewe Advisors held 1,072 positions worth $686M, up 8.8% from $630M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Crewe Advisors's Q1 2023 filing shows 55 new, 132 increased, 291 reduced and 261 closed positions. Its largest new stake was Magellan Midstream Partners, L.P.: 1,850 shares worth $100K. The largest sale was Invesco Preferred ETF, an estimated $7.11M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

  • Crewe Advisors's largest Q1 2023 buy was Magellan Midstream Partners, L.P.: 1,850 shares worth $100K.
  • Crewe Advisors added most to Vanguard Total Bond Market in Q1 2023, an estimated $11.9M increase.
  • Crewe Advisors's biggest Q1 2023 reduction was Invesco Preferred ETF, cutting an estimated $7.11M.
  • Crewe Advisors fully exited First Trust Rising Dividend Achievers ETF in Q1 2023, selling an estimated $87.8K.
  • Crewe Advisors's ten largest holdings make up 57% of its $686M portfolio in Q1 2023.
  • Crewe Advisors opened 55 new positions and closed 261 in Q1 2023.
  • Crewe Advisors's portfolio value rose 8.8% quarter-over-quarter to $686M.

Based on Crewe Advisors's 13F filing for Q1 2023, filed 12 May 2023.